on 12 Mar 2024
Last Applicant/ Owned by
4978 Santa Anita Avenue, Suite 205
Temple City
CA
91780
Serial Number
97822517 filed on 03rd Mar 2023
Registration Number
N/A
Correspondent Address
Jeffrey D. Morton
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMA"
Medical research in the field of oncology; clinical research in the field of oncology; pharmaceutical research and development in the field of oncology; research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; medical research, namely, research of nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-basedRead More
Medical research in the field of oncology; clinical research in the field of oncology; pharmaceutical research and development in the field of oncology; research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; medical research, namely, research of nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs
Pharmaceutical preparations, namely, nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs; medicinal preparations for treating cancer, namely, nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs
No 97822517
No Service Mark
No 13183207US01
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 12th Mar 2024 | PUBLISHED FOR OPPOSITION |
| 12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Jan 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 03rd Jan 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 03rd Jan 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
